计算溶液所需的质量、体积或浓度。
This is a demo store. No orders will be fulfilled.
| 货号 (SKU) | 包装规格 | 是否现货 | 价格 | 数量 |
|---|---|---|---|---|
| V101318-10mg |
10mg |
现货 ![]() |
| |
| V101318-20mg |
20mg |
现货 ![]() |
| |
| V101318-100mg |
100mg |
现货 ![]() |
|
| 别名 | 麦角甾苷 | 类叶升麻苷 | -(3,4-二羟苯基)乙基3-O-(6-脱氧-α-L-吡喃甘露糖基)-4-O-[(2E)-3-(3,4-二羟苯基)-2-丙烯酰基]-β-D-吡喃葡萄糖苷 |
|---|---|
| 英文别名 | Acteoside; Verbascoside | VERBASCOSIDE [INCI] | AKOS015897165 | Q-100706 | TJC 160 | 2-(3,4-dihydroxyphenyl)ethyl 3-O-(6-deoxy-alpha-L-mannopyranosyl)-4-O-((2E)-3-(3,4-dihydroxyphenyl)prop-2-enoyl)-beta-D-glucopyranoside | CCG-270269 | cid_24978601 | Verb |
| 规格或纯度 | Moligand™, 分析标准品, ≥99% |
| 英文名称 | Verbascoside |
| 生化机理 | PKC抑制剂。NF-κB抑制剂。增加PARP-1和p53。诱导细胞周期停滞和分化。抑制MMP(IC 50 = 32μM)。在体内显示出抗炎,抗伤害和抗氧化作用。 口服具有活性。 |
| 应用 | 苯乙醇糖苷。抗氧化和抗增殖。 |
| 储存温度 | 2-8°C储存,充氩 |
| 运输条件 | 冰袋运输 |
| 作用类型 | 通道阻滞剂 |
| 作用机制 | TRPV3 通道阻断剂 |
| 备注 | 如果有可能,您尽量在使用的当天配置溶液,并在当天使用完它。但是,如果您需要预先配制储备溶液,我们建议您将溶液等份保存在-20°C的密封小瓶中。通常,它们最多可以使用一个月。在使用前和打开样品瓶之前,我们建议您让您的产品在室温下平衡至少1小时。需要更多关于溶解度,用法和处理的建议吗?请访问我们的常见问题(FAQ)页面以获取更多详细信息。 |
| 产品介绍 |
苯乙醇糖苷。抗氧化和抗增殖。 Antioxidant and antiproliferative. Phenylethanoid glycoside. |
| 纯度 | ≥99% |
| 分子类型 | 小分子 |
|---|---|
| IIUPAC Name | [(2R,3R,4R,5R,6R)-6-[2-(3,4-dihydroxyphenyl)ethoxy]-5-hydroxy-2-(hydroxymethyl)-4-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-3-yl] (E)-3-(3,4-dihydroxyphenyl)prop-2-enoate |
| INCHI | 1S/C29H36O15/c1-13-22(36)23(37)24(38)29(41-13)44-27-25(39)28(40-9-8-15-3-6-17(32)19(34)11-15)42-20(12-30)26(27)43-21(35)7-4-14-2-5-16(31)18(33)10-14/h2-7,10-11,13,20,22-34,36-39H,8-9,12H2,1H3/b7-4+/t13-,20+,22-,23+,24+,25+,26+,27+,28+,29-/m0/s1 |
| InChi Key | FBSKJMQYURKNSU-ZLSOWSIRSA-N |
| Smiles | CC1C(C(C(C(O1)OC2C(C(OC(C2OC(=O)C=CC3=CC(=C(C=C3)O)O)CO)OCCC4=CC(=C(C=C4)O)O)O)O)O)O |
| Isomeric SMILES | C[C@H]1[C@@H]([C@H]([C@H]([C@@H](O1)O[C@@H]2[C@H]([C@@H](O[C@@H]([C@H]2OC(=O)/C=C/C3=CC(=C(C=C3)O)O)CO)OCCC4=CC(=C(C=C4)O)O)O)O)O)O |
| PubChem CID | 5281800 |
| 分子量 | 624.59 |
| 密度 | 1.6 |
|---|---|
| 敏感性 | 吸湿、对热敏感 |
| 比旋光度 | -92° (C=0.1,MeOH) |
| 分子量 | 624.600 g/mol |
| XLogP3 | -0.500 |
| 氢键供体数Hydrogen Bond Donor Count | 9 |
| 氢键受体数Hydrogen Bond Acceptor Count | 15 |
| 可旋转键计数Rotatable Bond Count | 11 |
| 精确质量Exact Mass | 624.205 Da |
| 单同位素质量Monoisotopic Mass | 624.205 Da |
| 拓扑极表面积Topological Polar Surface Area | 245.000 Ų |
| 重原子数Heavy Atom Count | 44 |
| 形式电荷Formal Charge | 0 |
| 复杂度Complexity | 936.000 |
| 同位素原子数Isotope Atom Count | 0 |
| 定义的原子立体中心计数Defined Atom Stereocenter Count | 10 |
| 未定义的原子立体中心计数Undefined Atom Stereocenter Count | 0 |
| 定义的键立体中心计数Defined Bond Stereocenter Count | 1 |
| 未定义的键立体中心计数Undefined Bond Stereocenter Count | 0 |
| 所有立体化学键的总数The total count of all stereochemical bonds | 1 |
| 共价键合单元计数Covalently-Bonded Unit Count | 1 |
| WGK Germany | 2 |
|---|---|
| RTECS | LZ5786000 |
通过匹配包装上的批号来查找并下载产品的 COA,每批产品都进行了严格的验证,您可放心使用!
| 批号(Lot Number) | 证书类型 | 货号 |
|---|---|---|
| 分析证书 | V101318 | |
| 分析证书 | V101318 | |
| 分析证书 | V101318 | |
| 分析证书 | V101318 | |
| 分析证书 | V101318 | |
| 分析证书 | V101318 | |
| 分析证书 | V101318 | |
| 分析证书 | V101318 | |
| 分析证书 | V101318 | |
| 分析证书 | V101318 | |
| 分析证书 | V101318 | |
| 分析证书 | V101318 | |
| 分析证书 | V101318 | |
| 分析证书 | V101318 | |
| 分析证书 | V101318 |
¥455.92
| 1. Fei Zhou, Weisu Huang, Tao Xu, Lipeng Wu, Qi Chen, Jiyu Peng, Xin Liu, Baiyi Lu. (2020) Natural P-gp inhibitor EGCG improves the acteoside absorption in Caco-2 cell monolayers and increases the oral bioavailability of acteoside in rats. FOOD AND CHEMICAL TOXICOLOGY, 146 (111827). [PMID:33184029] [10.1016/j.fct.2020.111827] |
| 2. Si-qi Wang, Xiao Yang, Yong-gang Zhang, En-bo Cai, Xiao-man Zheng, Yan Zhao, Ge Li, Mei Han, Li-min Yang. (2020) Study on the Changes of Chemical Constituents in Different Compatibilities of Ginseng-Prepared Rehmannia Root and Their Effects on Bone Marrow Inhibition after Chemotherapy. CHEMICAL & PHARMACEUTICAL BULLETIN, 68 (5): (428-435). [PMID:32188797] [10.1248/cpb.c19-00994] |
| 3. Fei Zhou, Tao Xu, Yajing Zhao, Huaxin Song, Liuquan Zhang, Xiaodan Wu, Baiyi Lu. (2018) Chitosan-coated liposomes as delivery systems for improving the stability and oral bioavailability of acteoside. FOOD HYDROCOLLOIDS, 83 (17). [10.1016/j.foodhyd.2018.04.040] |
| 4. Zhou Fei, Zhao Yajing, Li Maiquan, Xu Tao, Zhang Liuquan, Lu Baiyi, Wu Xiaodan, Ge Zhiwei. (2017) Degradation of phenylethanoid glycosides in Osmanthus fragrans Lour. flowers and its effect on anti-hypoxia activity. Scientific Reports, 7 (1): (1-10). [PMID:28855701] [10.1038/s41598-017-10411-0] |
| 5. Yong Jiang, Wenjun Ji, Ying Lu, Qin Wang, Linwei Chen. (2025) Integrating Plasma Metabolomics, Network Pharmacology, and Experimental Validation to Investigate the Action Mechanism of Qiangxin Lishui Prescription in Chronic Heart Failure. BIOMEDICAL CHROMATOGRAPHY, 39 (2): (e6065). [PMID:39748248] [10.1002/bmc.6065] |